Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 1999, p. 185-186, Vol. 43, No. 1
Department of Anti-Infectives, SmithKline
Beecham Pharmaceuticals, Collegeville,
Pennsylvania,1 and
SmithKline
Beecham Clinical Laboratories, Atlanta, Georgia2
Received 19 June 1998/Returned for modification 13 August
1998/Accepted 14 October 1998
Beta-Alert is a surveillance program developed in 1993 to monitor
the percentage of Haemophilus
influenzae causes a variety of community-acquired infections,
including acute otitis media, sinusitis, bronchitis, and pneumonia.
H. influenzae was considered to be susceptible to
all The purpose of this analysis was to identify trends in the percentage
of Specimens were collected from several locations, including physician
offices, clinics, and hospital clinical microbiology laboratories. The
specimens were transported to one of the 17 regional SBCL sites
described above. Specimens were processed, plated, and incubated
according to standard microbiological methods (6).
Isolates of H. influenzae were identified by standard
methods in specimens from blood, sputum, eye, nasal, ear, sinus, and throat (7). H. influenzae isolates were not
serotyped. H. influenzae was identified from throat
specimens if the isolate was present as the predominating organism or
as "heavy" growth. All isolates were assessed for
A total of 44,691 isolates of H. influenzae collected
during a 5-year period (1993 to 1997) were analyzed. The isolates were analyzed to determine the overall percentage of
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
A 5-Year Surveillance Study of 44,691 Isolates of
Haemophilus influenzae Project Beta-Alert
1993-1997
![]()
ABSTRACT
Top
Abstract
Text
References
-lactamase-producing Haemophilus
influenzae isolates obtained from specimens submitted to regional
commercial laboratories. The results of this study demonstrate that
levels of
-lactamase producers have remained between 31 and 38% in
the United States over the past 5 years.
![]()
TEXT
Top
Abstract
Text
References
-lactam antibiotics until 1974, when
-lactamase-mediated ampicillin resistance was first
reported (5). In a national surveillance study of 5,750 isolates of H. influenzae conducted in 1993, the
percentage of
-lactamase producing H. influenzae isolates was 33% (10). In a study of 1,539 clinical isolates of H. influenzae collected in 1994 to
1995 from 30 U.S. centers, a prevalence of
-lactamase-mediated ampicillin resistance of 36% was
reported (4).
-lactamase producers. Thousands of H. influenzae isolates are identified by SmithKline Beecham Clinical
Laboratories (SBCL) each year from a variety of clinical specimens.
Data from isolates of H. influenzae were collected
at regional SBCL sites between 1993 and 1997. Atlanta (Ga.),
Philadelphia (Pa.), Seattle (Wash.), St. Louis (Mo.), and Los
Angeles (Calif.) sites participated in the study from 1993 through 1997. Dallas (Tex.) and Chicago (Ill.) sites participated
beginning in 1994. In 1997, 10 additional laboratories were added to
the list of study sites. The new study sites were located in
Detroit (Mich.), Houston (Tex.), Lexington (Ky.), Minneapolis
(Minn.), New Orleans (La.), Nashville (Tenn.), New York (N.Y.), San
Francisco (Calif.), Tampa (Fla.), and Boston (Mass.).
-lactamase production by using the nitrocefin
-lactamase test (Cefinase; Becton-Dickinson Microbiology
Systems, Cockeysville, Md.) as established by the National Committee
for Clinical Laboratory Standards (9). Daily quality control
testing was performed according to manufacturers' recommendations.
Patient results were reported only when quality control results were acceptable.
-lactamase production. In addition, the data provided
the percentages and numbers of isolates that produce
-lactamase categorized by specimen source, patient age,
month of collection, SBCL site, state, and zip code. The percentage of
-lactamase producers ranged from 31% (1994) to 38%
(1996). The number and percentage of
-lactamase-producing H. influenzae
isolates analyzed per year are shown in Table
1. Seven regional SBCL sites participated
in the Beta-Alert surveillance program from 1993 to 1997 (Table
2). A total of 35,963 isolates were
collected from these seven regional SBCL sites. The percentage of
H. influenzae isolates producing
-lactamase were 33, 31, 37, 38, and 36%, for each
year from 1993 to 1997, respectively.
TABLE 1.
Number and percentage of
-lactamase
producing H. influenzae isolates, by year
TABLE 2.
Percentage of isolates that produce
-lactamase, categorized by SBCL site from 1994 to 1997
Children 6 years old and under provided the majority of
specimens, accounting for 39% of the isolates, and had the highest percentage of
-lactamase-producing isolates: 35, 41, 41, and 37%, respectively, during the period from 1994 to 1997. In 1993, the age group with the highest percentage of
-lactamase producing H. influenzae
was the 22- to 60-year-old group (37%). The results of this
study are consistent with previously published data (5), in
which isolates from children 5 years old and under had the highest
frequency of
-lactamase production. This may be related to high enrollment of children in day care centers, increased use of
antimicrobial agents in children, lack of patient compliance, and/or
inadequate dosing schedules (1, 3). Of the 44,691 H. influenzae isolates collected during the
period from 1993 to 1997, 19,384 were throat isolates, 7,898 were
sputum isolates, 5,007 were eye isolates, 5,212 were nasal isolates,
2,723 were ear isolates, 703 were sinus isolates, 102 were blood
isolates, 2,408 were from other sources, and 1,254 had no source
indicated. The source groups with the highest percentage of
-lactamase-producing organisms during the period from
1993 to 1997 were ear (46%), eye (49%), and sinus (46%). These
results are consistent with previously published data (5). The high
percentages of
-lactamase producers in ear specimens may
have clinical significance, since H. influenzae is
responsible for 20 to 35% of acute otitis media infections
(2).
Seasonal variation in the isolation of H. influenzae from clinical specimens was observed. The isolation frequency was highest in January and March and lowest in October.
The numbers of
-lactamase- and
non-
-lactamase-producing H. influenzae organisms isolated in each month of the surveillance period are shown in Fig. 1.
|
The percentage of
-lactamase-producing H. influenzae isolates was analyzed by zip codes along the
U.S.-Mexican and U.S.-Canadian borders. The percentage of
-lactamase producers was not calculated for countries
that had fewer than 10 isolates. During the period from 1994 to 1997, the percentage along the U.S.-Mexican border was 30% (n = 331) and the percentage along the U.S.-Canadian border was 35%
(n = 248).
In conclusion, the results of this study demonstrate that the
percentage of
-lactamase-producing H. influenzae isolates in the United States has remained high,
between 31 and 38%, for the past 5 years.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: SmithKline Beecham Pharmaceuticals, 1250 S. Collegeville Rd., UP1340, P.O. Box 5089, Collegeville, PA 19426-0989. Phone: (610) 917-7391. Fax: (610) 917-4617. E-mail: ann_m_derecola{at}sbphrd.com.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Calderon, E., C. Conde-Gonzalez, R. Gatica, R. Rivera, N. Hernando, G. Barriga, J. Hill, and G. Romero. 1993. Antimicrobial resistance among bacterial isolates from children. Curr. Ther. Res. 54:482-491. |
| 2. | Cohen, R. 1997. The antibiotic treatment of acute otitis media and sinusitis in children. Diagn. Microbiol. Infect. Dis. 27:35-39[Medline]. |
| 3. |
Dabernat, H.,
A. Scheimberg, and J. Astruc.
1996.
Analysis of oral antibiotic treatment that failed to prevent the development of Haemophilus influenzae meningitis: consequences on mortality.
J. Antimicrob. Chemother.
38:679-689 |
| 4. | Doern, G. 1995. Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. J. Am. Med. 99:6B-7S. |
| 5. |
Doern, G. V.,
A. B. Brueggemann,
G. Peirce,
H. P. Holley, Jr., and A. Rauch.
1997.
Antibiotic resistance among clinical isolates of Haemophlus influenzae in the United States in 1994 and 1995 and detection of -lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
Antimicrob. Agents Chemother.
41:292-297[Abstract].
|
| 6. | Isenberg, H. D. (ed.). 1998. Essential procedures for clinical microbiology, p. 3-36. American Society for Microbiology, Washington, D.C. |
| 7. | Isenberg, H. D. (ed.). 1998. Essential procedures for clinical microbiology, p. 37-126. American Society for Microbiology, Washington, D.C. |
| 8. | Jones, R. N., M. R. Jacobs, J. A. Washington, and M. A. Pfaller. 1997. A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United States. Diagn. Microbiol. Infect. Dis. 27:75-83[Medline]. |
| 9. | National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests, 6th ed. (M2-A6). National Committee for Clinical Laboratory Standards, Wayne, Pa. |
| 10. |
Rittenhouse, S. F.,
L. Miller,
R. L. Kaplan,
G. H. Mosely, and J. A. Poupard.
1995.
A survey of -lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolates.
Diagn. Microbiol. Infect. Dis.
21:223-225[Medline].
|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |